2016, Number 3
<< Back Next >>
Rev Méd Electrón 2016; 38 (3)
Frequency of the mutations C282Y and H63D of the HFE gene in patients diagnosed with deficiency of Alpha-1-Antitrypsin
Cervera GIA, García HM, Collazo MT
Language: Spanish
References: 11
Page: 361-369
PDF size: 69.79 Kb.
ABSTRACT
Introduction: Due to the high frequency of C282Y and H63D mutations in the HFE
gene, promoter type 1 hemochromatosis, and mutations S or Z causing the
deficiency of alpha-1-antitrypsin (def-A1AT), studies have shown their coexistence
in several patients. As a result, many scientists consider mutations in the HFE gene
as a possible contributor to the development of hepatic events in patients with
A1AT-def.
Aim: To determine the frequency of C268Y and H63D mutations in patients with
liver disease and presumptive diagnosis of A1AT-def.
Materials and methods: We conducted a descriptive study that involved 65
patients with liver disease who were referred to the Molecular Biology Laboratory of
the National Center of Medical Genetics for the molecular diagnosis of S and Z
mutations of the gene for alpha-1 antitrypsin. We used the polymerase chain
reaction method with polymorphisms in the sizes of the restriction fragments (PCRRFLP).
Results: The frequency of C282Y and H63D mutations of the HFE gene in patients
with presumptive diagnosis of deficiency of alpha-1 antitrypsin was 5.3% and 17%
respectively.
Conclusions: this study showed that the frequency of these two mutations in
Cuban population is high. We also observed that both of them, even in
heterozygous state, seem to play a main role in the development of different
diseases.
REFERENCES
Cervera García IA. Hemocromatosis tipo I. Patogenia y diagnóstico. Medisur [Internet]. 2012 [citado 12 mayo 2015];10(2): [aprox. 7 p.]. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/1727
Cervera García I, García Heredia M, Collazo Mesa T. Introducción del diagnóstico molecular de la hemocromatosis tipo 1 en Cuba. Finlay [Internet]. 2013 [citado 12 mayo 2015];3(2): [aprox. 6 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/119
Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012 Feb 1;185(3):246-59. Citado en PubMed; PMID: 21960536.
Blanco I, de Serres FJ, Cárcaba V, et al. Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method. Hepat Mon. 2012 Oct;12(10 HCC):e7434. Citado en PubMed; PMID: 23166537.
Büttner N, Spangenberg HC. Inherited disorders of liver metabolism. Ther Umsch. 2011 Apr;68(4):201-6. Citado en PubMed; PMID: 21452141.
Lam M, Torbenson M, et al. HFE mutations in α-1-antitrypsin deficiency: an examination of cirrhotic explants. Modern Pathology. 2010;23: 637–43. Citado en PubMed; PMID: 20208481.
Elzouki A, Hultcrantz R, Stdl P, et al . Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. Gut .1995;36:922-6. Citado en PubMed; PMID: 7615285.
Zaloumis SG, Allen KJ, Bertalli NA, et al. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study. J Gastroenterol Hepatol. 2015 Apr;30(4):719-25. Citado en PubMed; PMID: 25311314.
Cobbaert CM, Delanghe J, Boer JM, Feskens EJ. Regional differences of HFE (C282Y, H63D) allele frequencies in the Netherlands A model case illustrating the significance of genographics and prehistorical population migration. Acta Clin Belg. 2012 Nov-Dec;67(6):430-5. Citado en PubMed; PMID: 23340149.
Sassi R, Hmida S, Kaabi H, et al. Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population. Ann Génét. 2004;(47):325-30. Citado en PubMed; PMID: 15581829.
Settin A, El-Bendary M, Abo-Al-Kassem R, El Baz R. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis. J Gastrointestin Liver Dis. 2006;15:131-5. Citado en PubMed; PMID: 16802007.